A detailed history of Fca Corp transactions in Novartis Ag stock. As of the latest transaction made, Fca Corp holds 23,668 shares of NVS stock, worth $2.57 Million. This represents 0.83% of its overall portfolio holdings.

Number of Shares
23,668
Previous 23,249 1.8%
Holding current value
$2.57 Million
Previous $2.25 Million 12.06%
% of portfolio
0.83%
Previous 0.75%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$92.57 - $107.37 $38,786 - $44,988
419 Added 1.8%
23,668 $2.52 Million
Q1 2024

May 08, 2024

SELL
$95.27 - $108.47 $5,239 - $5,965
-55 Reduced 0.24%
23,249 $2.25 Million
Q4 2023

Feb 08, 2024

BUY
$92.27 - $101.54 $2,583 - $2,843
28 Added 0.12%
23,304 $2.35 Million
Q3 2023

Nov 13, 2023

BUY
$94.73 - $105.13 $71,047 - $78,847
750 Added 3.33%
23,276 $2.37 Million
Q2 2023

Aug 14, 2023

SELL
$92.52 - $104.91 $16,005 - $18,149
-173 Reduced 0.76%
22,526 $2.27 Million
Q1 2023

May 12, 2023

BUY
$80.03 - $92.81 $45,457 - $52,716
568 Added 2.57%
22,699 $2.09 Million
Q4 2022

Feb 13, 2023

BUY
$75.55 - $92.52 $5,666 - $6,939
75 Added 0.34%
22,131 $2.01 Million
Q3 2022

Nov 14, 2022

BUY
$74.61 - $87.26 $41,408 - $48,429
555 Added 2.58%
22,056 $1.68 Million
Q2 2022

Aug 12, 2022

BUY
$80.52 - $93.75 $24,961 - $29,062
310 Added 1.46%
21,501 $1.82 Million
Q1 2022

May 13, 2022

BUY
$80.11 - $90.62 $66,491 - $75,214
830 Added 4.08%
21,191 $1.86 Million
Q4 2021

Feb 14, 2022

SELL
$79.7 - $88.13 $251,134 - $277,697
-3,151 Reduced 13.4%
20,361 $1.78 Million
Q3 2021

Nov 12, 2021

BUY
$81.78 - $95.14 $19,708 - $22,928
241 Added 1.04%
23,512 $1.92 Million
Q2 2021

Aug 13, 2021

SELL
$85.24 - $94.15 $9,461 - $10,450
-111 Reduced 0.47%
23,271 $2.12 Million
Q1 2021

May 12, 2021

SELL
$83.5 - $98.47 $4,926 - $5,809
-59 Reduced 0.25%
23,382 $2 Million
Q4 2020

Feb 12, 2021

BUY
$78.07 - $94.43 $34,663 - $41,926
444 Added 1.93%
23,441 $2.21 Million
Q3 2020

Nov 12, 2020

SELL
$82.14 - $91.0 $36,305 - $40,222
-442 Reduced 1.89%
22,997 $2 Million
Q2 2020

Aug 13, 2020

SELL
$80.93 - $91.1 $3,156 - $3,552
-39 Reduced 0.17%
23,439 $2.05 Million
Q1 2020

May 20, 2020

BUY
$70.67 - $99.01 $38,444 - $53,861
544 Added 2.37%
23,478 $1.94 Million
Q4 2019

Feb 11, 2020

SELL
$84.35 - $95.37 $3,711 - $4,196
-44 Reduced 0.19%
22,934 $2.17 Million
Q3 2019

Nov 06, 2019

SELL
$85.54 - $94.26 $38,493 - $42,417
-450 Reduced 1.92%
22,978 $2 Million
Q2 2019

Aug 13, 2019

BUY
$75.4 - $92.8 $26,390 - $32,480
350 Added 1.52%
23,428 $2.14 Million
Q1 2019

May 14, 2019

SELL
$75.32 - $86.15 $25,533 - $29,204
-339 Reduced 1.45%
23,078 $2.22 Million
Q4 2018

Feb 14, 2019

SELL
$73.66 - $82.02 $13,111 - $14,599
-178 Reduced 0.75%
23,417 $2.01 Million
Q3 2018

Oct 22, 2018

SELL
$66.94 - $77.43 $19,345 - $22,377
-289 Reduced 1.21%
23,595 $2.03 Million
Q2 2018

Aug 13, 2018

BUY
$64.91 - $73.36 $1.55 Million - $1.75 Million
23,884 New
23,884 $1.8 Million
Q1 2018

May 14, 2018

SELL
$70.39 - $84.15 $1.72 Million - $2.06 Million
-24,437 Closed
0 $0
Q4 2017

Feb 13, 2018

SELL
$72.33 - $77.64 $7,956 - $8,540
-110 Reduced 0.45%
24,437 $2.05 Million
Q3 2017

Nov 09, 2017

BUY
$74.14 - $77.27 $1.82 Million - $1.9 Million
24,547
24,547 $2.11 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $233B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Fca Corp Portfolio

Follow Fca Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fca Corp , based on Form 13F filings with the SEC.

News

Stay updated on Fca Corp with notifications on news.